Table of Content

Table of Contents



Global Radiopharmaceuticals in Nuclear Medicine Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

1 Market Scope

1.1 Product Details and Introduction

1.1.1 Diagnostic Radiopharmaceuticals -Product Introduction and Major Manufacturers

1.1.2 Therapy Radiopharmaceuticals -Product Introduction and Major Manufacturers

1.1.3 Enriched Stable Isotopes -Product Introduction and Major Manufacturers

1.2 Market Snapshot

1.2.1 Major Companies Overview

1.2.2 Market Concentration

1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

2 Regional Market Analysis

2.1 China Radiopharmaceuticals in Nuclear Medicine Status and Prospect (2015-2026)

2.1.1 China Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2015-2026)

2.1.2 China Radiopharmaceuticals in Nuclear Medicine Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

2.2 EU Radiopharmaceuticals in Nuclear Medicine Status and Prospect (2015-2026)

2.2.1 EU Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2015-2026)

2.2.2 EU Radiopharmaceuticals in Nuclear Medicine Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

2.3 USA Radiopharmaceuticals in Nuclear Medicine Status and Prospect (2015-2026)

2.3.1 USA Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2015-2026)

2.3.2 USA Radiopharmaceuticals in Nuclear Medicine Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

2.4 Japan Radiopharmaceuticals in Nuclear Medicine Status and Prospect (2015-2026)

2.4.1 Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2015-2026)

2.4.2 Japan Radiopharmaceuticals in Nuclear Medicine Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

2.5 India Radiopharmaceuticals in Nuclear Medicine Status and Prospect (2015-2026)

2.5.1 India Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2015-2026)

2.5.2 India Radiopharmaceuticals in Nuclear Medicine Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

2.6 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Status and Prospect (2015-2026)

2.6.1 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2015-2026)

2.6.2 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

2.7 South America Radiopharmaceuticals in Nuclear Medicine Status and Prospect (2015-2026)

2.7.1 South America Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2015-2026)

2.7.2 South America Radiopharmaceuticals in Nuclear Medicine Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

2.8 Radiopharmaceuticals in Nuclear Medicine Status and Prospect (2015-2026)

2.8.1 Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2015-2026)

2.8.2 Radiopharmaceuticals in Nuclear Medicine Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

3 Global Radiopharmaceuticals in Nuclear Medicine Market Assessment by Segment

3.1 Global Radiopharmaceuticals in Nuclear Medicine Capacity and Growth Rate

3.2 Global Radiopharmaceuticals in Nuclear Medicine Sales by Type

3.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue by Type

3.4 Global Radiopharmaceuticals in Nuclear Medicine Consumption by Application

4 Global Radiopharmaceuticals in Nuclear Medicine Market Assessment by Regions

4.1 Global Radiopharmaceuticals in Nuclear Medicine Production Analysis and Forecast by Regions (2015-2026)

4.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Analysis and Forecast by Regions (2015-2026)

4.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue Analysis and Forecast by Regions (2015-2026)

5 Value Chain (Impact of COVID-19)

5.1 Radiopharmaceuticals in Nuclear Medicine Value Chain Analysis

5.1.1 Upstream

5.1.2 Downstream

5.2 COVID-19 Impact on Radiopharmaceuticals in Nuclear Medicine Industry

5.2.1 Industrial Policy Issued Under the Epidemic Situation

5.3 Cost-Under the Epidemic Situation

5.3.1 Cost of Raw Material

5.4 Channel Analysis

5.4.1 Distribution Channel-Under the Epidemic Situation

5.4.2 Distributors

6 Competitive Landscape

6.1 Global Radiopharmaceuticals in Nuclear Medicine Capacity Market Share of Manufacturers (2019-2020)

6.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share of Manufacturers (2019-2020)

6.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue Market Share of Manufacturers (2019-2020)



7 Radiopharmaceuticals in Nuclear Medicine Competitive Analysis

7.1 Bracco Imaging S.P.A.

7.1.1 Bracco Imaging S.P.A. Company Profiles

7.1.2 Bracco Imaging S.P.A. Product Introduction

7.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Production, Revenue (2015-2020)

7.1.4 SWOT Analysis

7.2 Cambridge Isotope Laboratories, Inc.

7.2.1 Cambridge Isotope Laboratories, Inc. Company Profiles

7.2.2 Cambridge Isotope Laboratories, Inc. Product Introduction

7.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Production, Revenue (2015-2020)

7.2.4 SWOT Analysis

7.3 Cardinal Health, Inc.

7.3.1 Cardinal Health, Inc. Company Profiles

7.3.2 Cardinal Health, Inc. Product Introduction

7.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Production, Revenue (2015-2020)

7.3.4 SWOT Analysis

7.4 Covidien, Plc

7.4.1 Covidien, Plc Company Profiles

7.4.2 Covidien, Plc Product Introduction

7.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Production, Revenue (2015-2020)

7.4.4 SWOT Analysis

7.5 Eczacibasi-Monrol

7.5.1 Eczacibasi-Monrol Company Profiles

7.5.2 Eczacibasi-Monrol Product Introduction

7.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Production, Revenue (2015-2020)

7.5.4 SWOT Analysis

7.6 Fujifilm Holdings Corporation

7.6.1 Fujifilm Holdings Corporation Company Profiles

7.6.2 Fujifilm Holdings Corporation Product Introduction

7.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Production, Revenue (2015-2020)

7.6.4 SWOT Analysis

7.7 GE Healthcare (Subsidiary Of General Electric Company)

7.7.1 GE Healthcare (Subsidiary Of General Electric Company) Company Profiles

7.7.2 GE Healthcare (Subsidiary Of General Electric Company) Product Introduction

7.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Production, Revenue (2015-2020)

7.7.4 SWOT Analysis

7.8 IBA Group

7.8.1 IBA Group Company Profiles

7.8.2 IBA Group Product Introduction

7.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Production, Revenue (2015-2020)

7.8.4 SWOT Analysis

7.9 Isotec, Inc. (Sigma-Aldrich)

7.9.1 Isotec, Inc. (Sigma-Aldrich) Company Profiles

7.9.2 Isotec, Inc. (Sigma-Aldrich) Product Introduction

7.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Production, Revenue (2015-2020)

7.9.4 SWOT Analysis

7.10 Lantheus Medical Imaging, Inc.

7.10.1 Lantheus Medical Imaging, Inc. Company Profiles

7.10.2 Lantheus Medical Imaging, Inc. Product Introduction

7.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Production, Revenue (2015-2020)

7.10.4 SWOT Analysis

7.11 Nordion, Inc.

7.12 Ntp Radioisotopes (Pty), Ltd.

7.13 Siemens Healthcare (Subsidiary Of Siemens AG)

7.14 Taiyo Nippon Sanso Corporation

7.15 Urenco Limited

7.16 Rotem Industries, Ltd., Inc.

7.17 Australian Nuclear Association And Technology Organization (ANSTO)

7.18 Board of Radiation And Isotope Technology (BRIT)

7.19 Institute of Atomic Energy Polatom Radioisotope Centre

7.20 Institute of Isotopes Co., Ltd.

7.21 Institute Of Radioelement (IRE)

8 Conclusion

List of Figure

List of Tables and Figures



Figure Product Introduction

Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)

Figure Global Radiopharmaceuticals in Nuclear Medicine Production Market Share of Top 5 Players

Table CAGR of Major Market (2021-2026)

Table CAGR in Terms of Production of Each Type (2015-2026)

Table CAGR in Terms of Production of Each Application (2015-2026)

Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Unit) by Type (2015-2026)

Figure Global Radiopharmaceuticals in Nuclear Medicine Sales (K Unit) and Growth Rate (2015-2026)

Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) by Type (2019 -2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Sales Value (Million USD) by Type (2015-2026)

Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Value (Million USD) and Growth Rate (2015-2026)

Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Value Market Share (%) by Type (2019-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Unit) by Application (2015-2026)

Figure China Radiopharmaceuticals in Nuclear Medicine Production Value (Million USD) and Growth Rate (2015-2026)

Table China Radiopharmaceuticals in Nuclear Medicine Local Capacity, Import, Export and Local Consumption (2015-2020)

Figure EU Radiopharmaceuticals in Nuclear Medicine Production Value (Million USD) and Growth Rate (2015-2026)

Table EU Radiopharmaceuticals in Nuclear Medicine Local Capacity, Import, Export and Local Consumption (2015-2020)

Figure North America Radiopharmaceuticals in Nuclear Medicine Production Value (Million USD) and Growth Rate (2015-2026)

Table North America Radiopharmaceuticals in Nuclear Medicine Local Capacity, Import, Export and Local Consumption (2015-2020)

Figure Japan Radiopharmaceuticals in Nuclear Medicine Production Value (Million USD) and Growth Rate (2015-2026)

Table Japan Radiopharmaceuticals in Nuclear Medicine Local Capacity, Import, Export and Local Consumption (2015-2020)

Figure India Radiopharmaceuticals in Nuclear Medicine Production Value (Million USD) and Growth Rate (2015-2026)

Table India Radiopharmaceuticals in Nuclear Medicine Local Capacity, Import, Export and Local Consumption (2015-2020)

Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Production Value (Million USD) and Growth Rate (2015-2026)

Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Local Capacity, Import, Export and Local Consumption (2015-2020)

Figure South America Radiopharmaceuticals in Nuclear Medicine Production Value (Million USD) and Growth Rate (2015-2026)

Table South America Radiopharmaceuticals in Nuclear Medicine Local Capacity, Import, Export and Local Consumption (2015-2020)

Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Production Value (Million USD) and Growth Rate (2015-2026)

Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Local Capacity, Import, Export and Local Consumption (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Capacity (K Units) and Growth Rate (2015-2026)

Figure Global Radiopharmaceuticals in Nuclear Medicine Capacity (K Units) and Growth Rate (2015-2026)

Table Global Radiopharmaceuticals in Nuclear Medicine Sales (Unit) by Type (2015-2026)

Figure Global Radiopharmaceuticals in Nuclear Medicine Sales(Unit) and Growth Rate (2015-2026)

Table Sales Market Share (%) by Type (2019-2026)

Table Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue (Million USD) by Type (2015-2026)

Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue (Million USD) and Growth Rate (2015-2026)

Table Sales Revenue Market Share (%) by Type (2019-2026)

Table Global Radiopharmaceuticals in Nuclear Medicine Consumption (Unit) by Application (2015-2026)

Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption (Unit) and Growth Rate (2015-2026)

Table Consumption Market Share (%) by Application (2019-2026)

Table Global Radiopharmaceuticals in Nuclear Medicine Production (K Unite) by Regions (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine CAGR (%) in term of Production and Market Share by Regions (2015-2026)

Figure Global Radiopharmaceuticals in Nuclear Medicine Production Share by Regions (2019-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Unite) by Regions (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine CAGR (%) in term of Sales and Market Share by Regions (2015-2026)

Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Regions (2019-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue (Million USD) by Regions (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)

Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue Share by Regions (2019-2020)

Figure Value Chain Structure of Radiopharmaceuticals in Nuclear Medicine

Table Value Chain

Table Key Suppliers of Raw Material/Components

Table Key Downstream Customer in Each Application Field

Table Industry News List of Radiopharmaceuticals in Nuclear Medicine

Figure Cost Structure of Radiopharmaceuticals in Nuclear Medicine in 2020

Table Global Radiopharmaceuticals in Nuclear Medicine Capacity Share of Manufacturers (2019-2020)

Figure Global Radiopharmaceuticals in Nuclear Medicine Capacity Share of Manufacturers (2019-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share of Manufacturers (2019-2020)

Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share of Manufacturers (2019-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue Market Share of Manufacturers (2019-2020)

Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue Market Share of Manufacturers (2019-2020)

Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Value (Million USD), Growth Rate & Market Share (2021-2026)

Table Bracco Imaging S.P.A. Profiles

Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product Introduction

Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Bracco Imaging S.P.A. SWOT Analysis

Table Cambridge Isotope Laboratories, Inc. Profiles

Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product Introduction

Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Cambridge Isotope Laboratories, Inc. SWOT Analysis

Table Cardinal Health, Inc. Profiles

Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product Introduction

Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Cardinal Health, Inc. SWOT Analysis

Table Covidien, Plc Profiles

Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product Introduction

Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Covidien, Plc SWOT Analysis

Table Eczacibasi-Monrol Profiles

Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product Introduction

Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Eczacibasi-Monrol SWOT Analysis

Table Fujifilm Holdings Corporation Profiles

Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product Introduction

Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Fujifilm Holdings Corporation SWOT Analysis

Table GE Healthcare (Subsidiary Of General Electric Company) Profiles

Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product Introduction

Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure GE Healthcare (Subsidiary Of General Electric Company) SWOT Analysis

Table IBA Group Profiles

Table IBA Group Radiopharmaceuticals in Nuclear Medicine Product Introduction

Table IBA Group Radiopharmaceuticals in Nuclear Medicine Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure IBA Group SWOT Analysis

Table Isotec, Inc. (Sigma-Aldrich) Profiles

Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product Introduction

Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Isotec, Inc. (Sigma-Aldrich) SWOT Analysis

Table Lantheus Medical Imaging, Inc. Profiles

Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product Introduction

Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Lantheus Medical Imaging, Inc. SWOT Analysis

Table Nordion, Inc. Profiles

Table Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product Introduction

Table Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Nordion, Inc. SWOT Analysis

Table Ntp Radioisotopes (Pty), Ltd. Profiles

Table Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product Introduction

Table Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Ntp Radioisotopes (Pty), Ltd. SWOT Analysis

Table Siemens Healthcare (Subsidiary Of Siemens AG) Profiles

Table Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product Introduction

Table Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Siemens Healthcare (Subsidiary Of Siemens AG) SWOT Analysis

Table Taiyo Nippon Sanso Corporation Profiles

Table Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product Introduction

Table Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Taiyo Nippon Sanso Corporation SWOT Analysis

Table Urenco Limited Profiles

Table Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product Introduction

Table Urenco Limited Radiopharmaceuticals in Nuclear Medicine Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Urenco Limited SWOT Analysis

Table Rotem Industries, Ltd., Inc. Profiles

Table Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product Introduction

Table Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Rotem Industries, Ltd., Inc. SWOT Analysis

Table Australian Nuclear Association And Technology Organization (ANSTO) Profiles

Table Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product Introduction

Table Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Australian Nuclear Association And Technology Organization (ANSTO) SWOT Analysis

Table Board of Radiation And Isotope Technology (BRIT) Profiles

Table Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product Introduction

Table Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Board of Radiation And Isotope Technology (BRIT) SWOT Analysis

Table Institute of Atomic Energy Polatom Radioisotope Centre Profiles

Table Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product Introduction

Table Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Institute of Atomic Energy Polatom Radioisotope Centre SWOT Analysis

Table Institute of Isotopes Co., Ltd. Profiles

Table Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product Introduction

Table Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Institute of Isotopes Co., Ltd. SWOT Analysis

Table Institute Of Radioelement (IRE) Profiles

Table Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product Introduction

Table Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Institute Of Radioelement (IRE) SWOT Analysis